{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 123,
  "authors": [
    {
      "name": "Andrés Poveda"
    },
    {
      "name": "Anne Floquet"
    },
    {
      "name": "Jonathan Ledermann"
    },
    {
      "name": "Rebecca Asher"
    },
    {
      "name": "Richard Penson"
    },
    {
      "name": "Amit Oza"
    },
    {
      "name": "Jacob Korach"
    },
    {
      "name": "Tomasz Huzarski"
    },
    {
      "name": "Sandro Pignata"
    },
    {
      "name": "Michael Friedlander"
    },
    {
      "name": "Alessandra Baldoni"
    },
    {
      "name": "Tjoung-Won Park-Simon"
    },
    {
      "name": "Kenji Tamura"
    },
    {
      "name": "Gabe Sonke"
    },
    {
      "name": "Alla Lisyanskaya"
    },
    {
      "name": "Jae-Hoon Kim"
    },
    {
      "name": "Elias Abdo Filho"
    },
    {
      "name": "Tsveta Milenkova"
    },
    {
      "name": "Elizabeth Lowe"
    },
    {
      "name": "Phil Rowe"
    },
    {
      "name": "Ignace Vergote"
    },
    {
      "name": "Eric Pujade-Lauraine"
    },
    {
      "name": "Jacob Korach"
    },
    {
      "name": "Tomasz Huzarski"
    },
    {
      "name": "Tomasz Byrski"
    },
    {
      "name": "Patricia Pautier"
    },
    {
      "name": "Michael Friedlander"
    },
    {
      "name": "Philipp Harter"
    },
    {
      "name": "Nicoletta Colombo"
    },
    {
      "name": "Sandro Pignata"
    },
    {
      "name": "Giovanni Scambia"
    },
    {
      "name": "Maria Nicoletto"
    },
    {
      "name": "Fiona Nussey"
    },
    {
      "name": "Andrew Clamp"
    },
    {
      "name": "Richard Penson"
    },
    {
      "name": "Amit Oza"
    },
    {
      "name": "Andrés Poveda Velasco"
    },
    {
      "name": "Manuel Rodrigues"
    },
    {
      "name": "Jean-Pierre Lotz"
    },
    {
      "name": "Frédéric Selle"
    },
    {
      "name": "Isabelle Ray-Coquard"
    },
    {
      "name": "Diane Provencher"
    },
    {
      "name": "Aleix Prat Aparicio"
    },
    {
      "name": "Laura Vidal Boixader"
    },
    {
      "name": "Clare Scott"
    },
    {
      "name": "Kenji Tamura"
    },
    {
      "name": "Mayu Yunokawa"
    },
    {
      "name": "Alla Lisyanskaya"
    },
    {
      "name": "Jacques Medioni"
    },
    {
      "name": "Nicolas Pécuchet"
    },
    {
      "name": "Coraline Dubot"
    },
    {
      "name": "Thibault de la Motte Rouge"
    },
    {
      "name": "Marie-Christine Kaminsky"
    },
    {
      "name": "Béatrice Weber"
    },
    {
      "name": "Alain Lortholary"
    },
    {
      "name": "Christine Parkinson"
    },
    {
      "name": "Jonathan Ledermann"
    },
    {
      "name": "Sarah Williams"
    },
    {
      "name": "Susana Banerjee"
    },
    {
      "name": "Jonathan Cosin"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/39rw2594m3dp6.bib",
  "cited_by": 425,
  "doi": "10.1016/s1470-2045(21)00073-5",
  "fulltext_url": null,
  "id": "39rw2594m3dp6",
  "issns": [
    "1470-2045",
    "1474-5488"
  ],
  "landing_url": "https://hal.science/hal-05742842v1",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "hal",
      "0.sdv"
    ],
    [
      "hal",
      "0.shs"
    ],
    [
      "openalex",
      "2730|PARP inhibition in cancer therapy"
    ]
  ],
  "openalex": "W4236289131",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-09-08",
  "publisher": "Elsevier",
  "ris": "https://research.draconitic.com/paper/39rw2594m3dp6.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:17:31Z",
      "native_id": "hal-05742842",
      "source": "hal",
      "url": "https://hal.science/hal-05742842v1"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|PARP inhibition in cancer therapy",
      "subfield": "oncology"
    }
  ],
  "title": "Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial",
  "title_text": "Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:17:31Z",
  "url": "https://research.draconitic.com/paper/39rw2594m3dp6",
  "venue": "Lancet Oncology",
  "versions": []
}